Ohio State Researches To Study Vaping
Researchers at Ohio State University are rolling out two new health studies aimed at learning more about smoking.
According to 10TV, the web division of WBNS-10TV that is located in Columbus, Ohio, a group of researchers from the Ohio State University Comprehensive Cancer Center’s Arthur G. James Cancer Hospital and Richard S. Solove Research Institute, known as OSUCCC-James, are currently looking for volunteers for two new clinical studies. These studies, which are funded by the FDA and the National Cancer Institute, aim to figure out whether or not vaping is, in fact, safer than smoking.
Both studies are searching for smokers, with the first also looking for non-smokers, vape users, and smokeless tobacco users. This study focuses on whether or not vaping affects lung function differently than traditional cigarettes. The second study focuses on if vaping and other tobacco products, such as traditional cigarettes, expose consumers to cancer-causing chemicals and other toxins found in cigarettes.
If these studies sound familiar to you, it’s because we have reported on similar studies in the past, including a specific study that marked the different carcinogens that were found in cigarettes but absent in vape products.
The clinical trials are part of a research project that was announced at the beginning of this month. Peter Shields, MD, who is the deputy director of the OSUCCC and the leading thoracic medical oncologist at The James, spoke at a press function, saying that: “We are concerned that people assume these products have fewer negative health effects as compared with cigarettes and other tobacco products. The reality is that they are still a tobacco product, and people are still inhaling potentially harmful chemicals. They should not be considered a ‘safer’ option until science has the opportunity to catch up with the consumer market.”
This statement may come as a shock to many within the vape industry, as several studies have shown that vaping is safer than smoking. In fact, Public Health England, the country’s department of health, has even urged employers in the UK to encourage vaping as an alternative to smoking. And even India and New Zealand, who both were previously wary of vaping, have begun welcoming the idea that vaping may be a safer alternative to smoking.
It’s also interesting to note that while Shields says that vaping products are tobacco products, that is a generalization. As we’ve reported before, synthetic nicotine is on the rise in the industry, and there are already products on the market that contain no tobacco whatsoever.
While we are reasonably sure that these studies will be objective, it would be irresponsible for us to complete this article without voicing our concern of the potential for bias from the OSUCCC-James. Because these studies are being funded by the FDA and the National Cancer Institute, both which have been vocal against vaping, we are acutely aware that these organizations may play a factor in the conclusion. However, the OSUCCC-James will no doubt feel pressure from all sides to be objective, so we remain hopeful that the conclusion will be based in fact and not mired in politics.